(Date:12/1/2009)... , NEW YORK, Dec. 1 Reportlinke...is available in its catalogue: ,, Chromium - ...ker.com/p0164494/Chromium---Global-Market-Trends.h...ily influenced by stainless steel, while growth in...lso important for growth of chromium metal. Enviro...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Reportlinke...is available in its catalogue: ,, Emerging Cli...amics and the changing healthcare and regulatory e...65658/Emerging-Clinical-Trial-Locations---Eastern-...-and-regulatory-environment.html ,, Over the l...
(Date:12/1/2009)... , CAMBRIDGE, Mass., Dec. 1 To...dustry and to promote its potential, a group of in... the Synthetic Biology Industry Association (SynBI... of the association is to provide a forum for indi...w industry, address its opportunities and its chal...
(Date:12/1/2009)... SHANGHAI, Dec. 1 /PRNewswire-Asia/ -- Shangha...Pharma, a leading China-based Contract Research,Or...f the 2009 Deloitte,Technology Fast 50 China, rank...ch companies in China. The award is a testament to...th from 2006 to 2008. , The results of th...
Breaking Biology Technology:Reportlinker Adds Chromium - Global Market Trends 2Reportlinker Adds Chromium - Global Market Trends 3Reportlinker Adds Chromium - Global Market Trends 4Reportlinker Adds Chromium - Global Market Trends 5Reportlinker Adds Chromium - Global Market Trends 6Reportlinker Adds Chromium - Global Market Trends 7Reportlinker Adds Chromium - Global Market Trends 8Reportlinker Adds Chromium - Global Market Trends 9Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8Industry Forms Association to Address Opportunities and Challenges of Synthetic Biology 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3...atory-Oriented Consulting Unit to Use Pharsight, ...al and Clinical Data, MOUNTAIN VIEW, Calif., Feb....ding provider of software, strategic,consulting, a...g,development, today announced that its Reporting ...e of a validated enterprise product for data,manag...
...eb. 28 Memory,Pharmaceuticals Corp. (Nasdaq: MEM... quarter and full year 2007 financial results on T...markets open. Management will provide a,Company up...nference call,on Thursday, March 6, 2008, at 9:00 ...ies may access the call as follows:, Date: ...
...yowa Hakko Kogyo Co., Ltd. (President:,Dr. Yuzuru ... (New Jersey,United States), its wholly owned U.S....ime) a Not approvable letter from the U.S. Food an...-6002), its investigational drug,for the treatment...etter FDA expressed concern if the efficacy,findin...
Other Biology Technology:Pharsight's Reporting and Analysis Services Business Unit to Leverage New Validated Data Management System 2Pharsight's Reporting and Analysis Services Business Unit to Leverage New Validated Data Management System 3Pharsight's Reporting and Analysis Services Business Unit to Leverage New Validated Data Management System 4Memory Pharmaceuticals to Announce Fourth Quarter and Full Year 2007 Results on Thursday, March 6, 2008 2Kyowa Hakko Receives Not Approvable Letter from FDA for Istradefylline (KW-6002) 2Anti-Human Apolipoprotein B100 Affinity Purified Polyclonal Antibody, Unconjugated from R&D Systems
Anti-Mouse Ameloblastin Affinity Purified Polyclonal Antibody, Biotin Conjugated from R&D Systems
Goat Anti-Human SOST Polyclonal Antibody, Unconjugated from R&D Systems
Rabbit Anti-Human CDC23 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Biology Products: